These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
181 related articles for article (PubMed ID: 35280775)
41. IWR-1, a tankyrase inhibitor, attenuates Wnt/β-catenin signaling in cancer stem-like cells and inhibits in vivo the growth of a subcutaneous human osteosarcoma xenograft. Martins-Neves SR; Paiva-Oliveira DI; Fontes-Ribeiro C; Bovée JVMG; Cleton-Jansen AM; Gomes CMF Cancer Lett; 2018 Feb; 414():1-15. PubMed ID: 29126913 [TBL] [Abstract][Full Text] [Related]
42. Polyphyllin I suppresses human osteosarcoma growth by inactivation of Wnt/β-catenin pathway in vitro and in vivo. Chang J; Li Y; Wang X; Hu S; Wang H; Shi Q; Wang Y; Yang Y Sci Rep; 2017 Aug; 7(1):7605. PubMed ID: 28790389 [TBL] [Abstract][Full Text] [Related]
43. FGF-induced Li SQ; Tu C; Wan L; Chen RQ; Duan ZX; Ren XL; Li ZH Cell Div; 2019; 14():13. PubMed ID: 31788020 [TBL] [Abstract][Full Text] [Related]
44. A comprehensive analysis of Wnt/β-catenin signaling pathway-related genes and crosstalk pathways in the treatment of As Li YL; Jin YF; Liu XX; Li HJ Ren Fail; 2018 Nov; 40(1):331-339. PubMed ID: 29633893 [TBL] [Abstract][Full Text] [Related]
45. Gallic acid mediates tumor-suppressive effects on osteosarcoma through the H19-Wnt/β-catenin regulatory axis. Pang F; Ding S; Li N; Li Z; Tian N; Shi C; Zhang F; Mai Y; Zhang J; Wang J J Orthop Translat; 2023 Mar; 39():34-42. PubMed ID: 36636358 [TBL] [Abstract][Full Text] [Related]
46. Identification of key biomarkers and functional pathways in osteosarcomas with lung metastasis: Evidence from bioinformatics analysis. Liu D; Zhou R; Zhou A Medicine (Baltimore); 2021 Feb; 100(6):e24471. PubMed ID: 33578541 [TBL] [Abstract][Full Text] [Related]
47. Cinobufacini Inhibits Colon Cancer Invasion and Metastasis via Suppressing Wnt/β-Catenin Signaling Pathway and EMT. Wang J; Cai H; Liu Q; Xia Y; Xing L; Zuo Q; Zhang Y; Chen C; Xu K; Yin P; Chen T Am J Chin Med; 2020; 48(3):703-718. PubMed ID: 32329642 [TBL] [Abstract][Full Text] [Related]
48. Identification of a novel gene signature with regard to ferroptosis, prognosis prediction, and immune microenvironment in osteosarcoma. Zheng D; Xia K; Wei Z; Wei Z; Guo W Front Genet; 2022; 13():944978. PubMed ID: 36330451 [TBL] [Abstract][Full Text] [Related]
49. Zinc finger Asp-His-His-Cys palmitoyl -acyltransferase 19 accelerates tumor progression through wnt/β-catenin pathway and is upregulated by miR-940 in osteosarcoma. Liang S; Zhang X; Li J Bioengineered; 2022 Mar; 13(3):7367-7379. PubMed ID: 35297315 [TBL] [Abstract][Full Text] [Related]
50. Baicalein mediates the anti-tumor activity in Osteosarcoma through lncRNA-NEF driven Wnt/β-catenin signaling regulatory axis. Zhang FW; Peng LY; Shi CJ; Li JC; Pang FX; Fu WM; Pan XH; Zhang JF J Orthop Translat; 2022 Mar; 33():132-141. PubMed ID: 35330943 [TBL] [Abstract][Full Text] [Related]
51. Downregulation of the Proton-Activated Cl- Channel TMEM206 Inhibits Malignant Properties of Human Osteosarcoma Cells. Peng F; Li H; Li J; Wang Z Oxid Med Cell Longev; 2021; 2021():3672112. PubMed ID: 34777684 [TBL] [Abstract][Full Text] [Related]
52. Hsa_circ_0087302, a circular RNA, affects the progression of osteosarcoma via the Wnt/β-catenin signaling pathway. Peng L; Liu Q; Wu T; Li P; Cai Y; Wei X; Zeng Y; Ye J; Chen P; Huang J; Lin H Int J Med Sci; 2022; 19(9):1377-1387. PubMed ID: 36035366 [TBL] [Abstract][Full Text] [Related]
53. miR-885-5p suppresses osteosarcoma proliferation, migration and invasion through regulation of β-catenin. Liu Y; Bao Z; Tian W; Huang G Oncol Lett; 2019 Feb; 17(2):1996-2004. PubMed ID: 30675266 [TBL] [Abstract][Full Text] [Related]
54. Osteosarcoma subtypes based on platelet-related genes and tumor microenvironment characteristics. Shu Y; Peng J; Feng Z; Hu K; Li T; Zhu P; Cheng T; Hao L Front Oncol; 2022; 12():941724. PubMed ID: 36212395 [TBL] [Abstract][Full Text] [Related]
55. Inhibition of the Wnt-β-catenin and Notch signaling pathways sensitizes osteosarcoma cells to chemotherapy. Ma Y; Ren Y; Han EQ; Li H; Chen D; Jacobs JJ; Gitelis S; O'Keefe RJ; Konttinen YT; Yin G; Li TF Biochem Biophys Res Commun; 2013 Feb; 431(2):274-9. PubMed ID: 23291185 [TBL] [Abstract][Full Text] [Related]
56. Evodiamine Exerts Anticancer Effects Against 143B and MG63 Cells Through the Wnt/β-Catenin Signaling Pathway. Yang S; Chen J; Tan T; Wang N; Huang Y; Wang Y; Yuan X; Zhang P; Luo J; Luo X Cancer Manag Res; 2020; 12():2875-2888. PubMed ID: 32425601 [TBL] [Abstract][Full Text] [Related]
57. Baicalein inhibits progression of osteosarcoma cells through inactivation of the Wnt/β-catenin signaling pathway. Dai G; Zheng D; Wang Q; Yang J; Liu G; Song Q; Sun X; Tao C; Hu Q; Gao T; Yu L; Guo W Oncotarget; 2017 Oct; 8(49):86098-86116. PubMed ID: 29156780 [TBL] [Abstract][Full Text] [Related]
58. Apigenin inhibits the proliferation and invasion of osteosarcoma cells by suppressing the Wnt/β-catenin signaling pathway. Liu X; Li L; Lv L; Chen D; Shen L; Xie Z Oncol Rep; 2015 Aug; 34(2):1035-41. PubMed ID: 26035210 [TBL] [Abstract][Full Text] [Related]
59. Carboxypeptidase E-ΔN promotes migration, invasiveness, and epithelial-mesenchymal transition of human osteosarcoma cells via the Wnt-β-catenin pathway. Fan S; Gao X; Chen P; Li X Biochem Cell Biol; 2019 Aug; 97(4):446-453. PubMed ID: 30508384 [TBL] [Abstract][Full Text] [Related]
60. CCR9 initiates epithelial-mesenchymal transition by activating Wnt/β-catenin pathways to promote osteosarcoma metastasis. Kong H; Yu W; Chen Z; Li H; Ye G; Hong J; Xie Z; Chen K; Wu Y; Shen H Cancer Cell Int; 2021 Dec; 21(1):648. PubMed ID: 34863167 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]